thesiliconreview11h
Medicare Expands Coverage for Eli Lilly’s Zepbound Drug
Medicare has announced the expansion of coverage for Eli Lilly’s Zepbound, a breakthrough drug in the treatment of autoimmune ...
Fierce Healthcare4h
Payer Roundup—UnitedHealth tagged with $165M fine; Scripps Health out of network with Anthem Blue Cross
Below is a roundup of payer-centric news headlines you may have missed during the month of January 2025. | You may have ...
Lilly in advanced talks to buy cancer biotech Scorpion for up to $2.5B, FT says
Eli Lilly (LLY) is in advanced talks to buy cancer-focused biotech Scorpion Therapeutics in a deal worth up to $2.5B, people close to the talks ...
Balanced Outlook on ResMed: Strong Execution and Innovations Offset by Valuation Concerns and Market Challenges
Adam Maeder, an analyst from Piper Sandler, has initiated a new Hold rating on Resmed (RMD).Stay Ahead of the Market:Discover outperforming ...
Australian Broadcasting Corporation16h
South Australia
Calling people "mentally ill" based on their sexual identity and referring to women as "household objects" will now be allowed in the context of political discussions on social media giant Meta's ...